.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Julphar
McKesson
US Army
Moodys
Johnson and Johnson
Medtronic
Mallinckrodt
Federal Trade Commission
Express Scripts

Generated: July 25, 2017

DrugPatentWatch Database Preview

KENALOG Drug Profile

« Back to Dashboard

Which patents cover Kenalog, and when can generic versions of Kenalog launch?

Kenalog is a drug marketed by Mylan Pharms Inc, Delcor Asset Corp, Ranbaxy Labs Ltd, and Apothecon. and is included in ten NDAs.

The generic ingredient in KENALOG is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for Tradename: KENALOG

Patents:0
Applicants:4
NDAs:10
Suppliers / Packagers: see list1
Clinical Trials: see list40
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KENALOG at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
KENALOG
triamcinolone acetonide
OINTMENT;TOPICAL011600-003Approved Prior to Jan 1, 1982ATRXNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL084343-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL011602-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Apothecon
KENALOG-40
triamcinolone acetonide
INJECTABLE;INJECTION014901-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL084343-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Julphar
Chubb
Fuji
US Army
Accenture
AstraZeneca
Dow
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot